Search

everythinglearnresearchcommunity

for

Search:↓

Human skin acts like a hormone-producing organ, making and managing various hormones important for skin and hair health.

Cannabinoids may help treat various skin conditions.

Retinoic acid-binding proteins in skin are regulated by β-catenin and Notch signalling.

The project created a standardized system for classifying skin lesions in lab rats and mice.

Reducing Tyrosinase prevents mature color pigment cells from forming in mouse hair.

Cholesterol-modified siRNAs targeting certain genes increased hair growth in mice.

Sox9 is present in most canine skin tumors and may help understand stem cells' role in these cancers.

Regenerative cellular therapies show promise for treating non-scarring hair loss but need more research.

Fetal hair follicles have melanocytes with melanosomes at different stages, which are broken down into pigment particles in keratinocytes.

Early treatment of Lupus Erythematosus Alopecia can prevent permanent hair loss, and various medications are effective.

Choosing the right method to separate skin layers is key for good skin cell research.

Different types of resting melanocyte stem cells have unique characteristics and vary in their potential to become other cells.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

The human scalp hair bulb contains different types of melanocytes with varying abilities to produce melanin.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

An 8-year-old boy had both alopecia areata and vitiligo on the same spot on his scalp, which is very rare.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

SCF and c-Kit decrease in AGA hair follicles, possibly affecting hair pigmentation and growth.

Vitiligo affects overall health and self-esteem, needing more research and awareness.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Vitiligo is often found with other autoimmune diseases, which is important to know to help patients.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.